✦ LIBER ✦

Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure

✍ Scribed by Hielke J. Meulenbeld; Jean P. Bleuse; Elio M. Vinci; Eric Raymond; Giordano Vitali; Armando Santoro; Luigi Dogliotti; Rossana Berardi; Federico Cappuzzo; Scott T. Tagawa; Cora N. Sternberg; Maria G. Jannuzzo; Mariangela Mariani; Anna Petroccione; Ronald de Wit

Book ID: 117949736
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 245 KB
Volume: 111
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2012.11404.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel reintroduction in patients wit

Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study

✍ Jean-Christophe Eymard; Stéphane Oudard; Gwenaelle Gravis; Jean-Marc Ferrero; Ch 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

Phase II study of docetaxel re-treatment

Phase II study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer

✍ Giuseppe Di Lorenzo; Carlo Buonerba; Adriana Faiella; Pasquale Rescigno; Mimma R 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB

Randomised phase II/III study of docetax

Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)

✍ H.J. Meulenbeld; E.D. van Werkhoven; J.L.L.M. Coenen; G.J. Creemers; O.J.L. Loos 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 674 KB

Phase II trial of cisplatin plus prednis

Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients

✍ Carlo Buonerba; Piera Federico; Carmine D’Aniello; Pasquale Rescigno; Carla Cava 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 180 KB

761 PREDICTION OF LEUKOPENIA AFTER DOCET

761 PREDICTION OF LEUKOPENIA AFTER DOCETAXEL CHEMOTHERAPY IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER

✍ Nakashima, Jun; Takizawa, Issei; Ko, Kazuyoshi; Nakagami, Yoshihiro; Ohori, Mako 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 96 KB

Phase I trial with a combination of doce

Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer

✍ Jianqing Lin; Victoria J. Sinibaldi; Michael A. Carducci; Samuel Denmeade; Danny 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 296 KB